DCM Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
DCM Advisors's PFE Position: Q1 2026 in Review
DCM Advisors reduced its Pfizer (PFE) stake by 2.6% in Q1 2026, selling an estimated $21.9K and leaving 30,714 shares worth $862K. The position accounts for 0.39% of the portfolio, ranked #36.
DCM Advisors first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.12M in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- DCM Advisors held 30,714 shares of Pfizer worth $862K as of Q1 2026.
- DCM Advisors sold 822 Pfizer shares in Q1 2026, an estimated $21.9K.
- Pfizer made up 0.39% of DCM Advisors's portfolio in Q1 2026, its #36 holding.
- DCM Advisors first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
- DCM Advisors's Pfizer position peaked at $3.12M in Q4 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on DCM Advisors's 13F filing for Q1 2026, filed 15 May 2026.